China’s first counter-sanction on US biotech industry marks a turning point in tech war
China’s Ministry of Commerce announced on Tuesday the inclusion of a major US biotech company on its “unreliable entity list” while stating that the firm’s “discriminatory measures against Chinese enterprises” harmed the legitimate rights and interests of Chinese companies. Leading American genomic sequencing firm Illumina is the first biotech company on Beijing’s list. More than…
